Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126644822 | 12664482 | 2 | F | 2015 | 20160907 | 20160818 | 20160914 | PER | US-PFIZER INC-2016365219 | PFIZER | 62.00 | YR | F | Y | 81.00000 | KG | 20160914 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126644822 | 12664482 | 1 | PS | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 125 UG, DAILY | Y | 0 | 125 | UG | |||||||
| 126644822 | 12664482 | 2 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, 1X/DAY (NIGHTLY) | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126644822 | 12664482 | 1 | Hypothyroidism |
| 126644822 | 12664482 | 2 | Hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126644822 | 12664482 | Arthralgia | |
| 126644822 | 12664482 | Constipation | |
| 126644822 | 12664482 | Drug ineffective | |
| 126644822 | 12664482 | Gastrointestinal motility disorder | |
| 126644822 | 12664482 | Muscle spasms |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126644822 | 12664482 | 1 | 2015 | 2015 | 0 | |
| 126644822 | 12664482 | 2 | 2013 | 0 |